Immunohistochemical evaluation for integrin binding sialoprotein on healing process of intrabony defect treated by bone sialoprotein
Main Article Content
Abstract
Background: Bone defect healing is a multidimensional procedure with an overlapping timeline that involves the regeneration of bone tissue. Due to bone's ability to regenerate, the vast majority of bone abnormalities can be restored intuitively under the right physiological conditions. The goal of this study is to examine the immunohistochemistry of bone sialoprotein in order to determine the effect of local application of bone sialoprotein on the healing of a rat tibia generated bone defect. Materials and Methods: In this experiment, 48 albino male rats weighing 300-400 grams and aged 6-8 months will be employed under controlled temperature, drinking, and food consumption settings. The animals will be subjected to a surgical procedure on the medial side of the tibiae bone, with the bone defect repaired with absorbable hemostatic material in the control group (12 rats). The experimental group (12 rats) will be treated with local administration of 30 μl bone sialoprotein fixed by absorbable hemostatic sponge. After surgery, the rats will be slaughtered at 7, 14, and 28 days (four rats for each period). Results: Immunohistochemical analysis of bone sialoprotein by stromal cells reveal a substantial difference between the bone sialoprotein group and the control group. Conclusion: The study concludes that local application of bone sialoprotein could be a successful therapeutic treatment for bone injuries; these findings are encouraging for future clinical use.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
References
Prodinger P M, Bürklein D, Foehr P, Kreutzer K, Pilge H, Schmitt A, ... & Tischer T. Improving results in rat fracture models: enhancing the efficacy of biomechanical testing by a modification of the experimental setup. Bmc musculoskeletal disorders, 2018; 19(1): 243.
Oury F, Khrimian L, Denny C A, Gardin A, Chamouni A, Goeden N, ... & Suyama S. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell, 2013; 155(1): 228-241.
Nikel O, Poundarik A A, Bailey S, & Vashishth D. Structural role of osteocalcin and osteopontin in energy dissipation in bone. Journal of biomechanics. 2018; 80: 45-52.
Aubin JE. Osteogenic cell differentiation. In: Davies JE. Bone engineering.2000; 19–30.
Haley S, Gulliver K, Baldassarre R,Miller S, Lane R and Moyer-Mileur L.Tactile and Kinesthetic Stimulation (TKS) intervention improves outcomes in weanling rat bone in a neonatal stress model.J Musculoskelet Neuronal Interact. 2013; 13(2):157-165.
Sodek J and Mckee M. Molecular and cellular biology of alveolar bone.Peridontol. 2000; 24:99-126.
Jamil B. Role of biomaterial collagen coated titanium implant surface on expression of bone protein markers and osseointegration reaction, in comparison to titanium implant coated with zirconia. PhD thesis, collage of Dentistry, University of Baghdad .2011.
Gorski J P, Wang A, Lovitch D, Law D, Powell K & Midura R J J J O B C. Extracellular bone acidic glycoprotein-75 defines condensed mesenchyme regions to be mineralized and localizes with bone sialoprotein during intramembranous bone formation. 2004; 279: 25455-25463.
Bouet G, Bouleftour W, Juignet L, Linossier M T, Thomas M , Vanden-Bossche A, Aubin J E, Vico L, Marchat D & Malaval L J P O. The impairment of osteogenesis in bone sialoprotein (BSP) knockout calvaria cell cultures is cell density dependent. 2015; 10: e0117402.
Gordon J A, Ttye C E, Ssampaio A V, Underhill T M, Hunter G K & Goldberg H A J B. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. 2007; 41: 462-473.
Baht G S, Hunter G K & Goldberg H A JM B. Bone sialoprotein–collagen interaction promotes hydroxyapatite nucleation. 2008; 27: 600-608.
Fisher L W & Fedarko N S J C T R. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. 2003; 44: 33-40.
O'loughlin P F, Morr S, Bogunovic L, Kim A D, Park B & Lane J M. Selection and development of preclinical models in fracture-healing research. 2008; JBJS, 90(Supplement_1): 79-84.
Zhu B, Guo Z, Lin L & Liu Q J E R M P S. Serum BSP, PSADT, and Spondin-2 levels in prostate cancer and the diagnostic significance of their ROC curves in bone metastasis. 2017; 21: 61-67.
Bäuerle T, Peterschmitt J, Hilbig H , Kiessling F, Armbruster F P & Berger M R J I J O O. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. 2006; 28: 573-583.
Zepp M, Kovacheva M, Altankhuyag M,Westphal G, Berger I, Gather K S, Hilbig H, Neuhaus J, Hänsch G M & Armbruster F P J T J O P C R. IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis. 2018;4: 55-68.
Chen J, Mcculloch C A. & Sodek J J A O O B. Bone sialoprotein in developing porcine dental tissues: cellular expression and comparison of tissue localization with osteopontin and osteonectin. 1993; 38: 241-249.
Pinero G J, Farach-carson M C, Devoll R E, Aubin J E, Brunn J C& Butler W T JA O O B. Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, α2HS-glycoprotein and alkaline phosphatase. 1995; 40: 145-155.
Arambawatta A K S, Yamamoto T & Wakita M J A O A A A. Immunohistochemical characterization of noncollagenous matrix molecules on the alveolar bone surface at the initial principal fiber attachment in rat molars. 2005; 187: 77-87.
Ivanovski S, Li H, Daley T & Bartold P J J O P R. An immunohistochemical study of matrix molecules associated with barrier membrane‐mediated periodontal wound healing. 2000; 35: 115-126
Ishigaki R, Takagi M, Igarashi M & Ito K J T H J. Gene expression and immunohistochemical localization of osteonectin in association with early bone formation in the developing mandible. 2002; 34: 57-66.
Tera T D M, Nascimento R D, Prado R F D, Santamaria M P & Jardini M A N J J O A O S. Immunolocalization of markers for bone formation during guided bone regeneration in osteopenic rats. 2014; 22: 541-553.
Chen J, Shapiro H S, Sodek J J J O B & research M. 1992. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. 1992; 7: 987-997.